Articles from Antidepressants

Primary tabs

VistaGen Therapeutics (VTGN) Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - StreetInsider.com

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:33

VistaGen Therapeutics (VTGN) Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder StreetInsider.com

Read more about VistaGen Therapeutics (VTGN) Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - StreetInsider.com
Log in to post comments

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - Yahoo Finance

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:30

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder Yahoo Finance

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - Yahoo Finance

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:30

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder Yahoo Finance

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - Business Wire

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:30

Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder Business Wire

Biogen Inc., Sage Therapeutics, Inc. - Special Call - Marketscreener.com

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:00

Biogen Inc., Sage Therapeutics, Inc. - Special Call Marketscreener.com

Read more about Biogen Inc., Sage Therapeutics, Inc. - Special Call - Marketscreener.com
Log in to post comments

ViiV works with private organizations in hopes of ending HIV within the decade - FiercePharma

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 12:30

ViiV works with private organizations in hopes of ending HIV within the decade FiercePharma

Fighting the war with drugs: How can psychedelic-assisted therapies help veterans? - PoliticsHome

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 11:54

Fighting the war with drugs: How can psychedelic-assisted therapies help veterans? PoliticsHome

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry | Scientific Reports - Nature.com

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 10:47

Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry | Scientific Reports Nature.com

Queeries: Should I come off my SSRIs? - gal-dem

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 10:32

Queeries: Should I come off my SSRIs? gal-dem

Read more about Queeries: Should I come off my SSRIs? - gal-dem
Log in to post comments

Pain Management Drugs Market Increasing Demand to Make Highest Revenue Value at 89323.54 Million by End of 2027 | Latest Updated 102 Pages Report - Digital Journal

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 08:32

Pain Management Drugs Market Increasing Demand to Make Highest Revenue Value at 89323.54 Million by End of 2027 | Latest Updated 102 Pages Report Digital Journal

Pages